Fetal-Cell Revival for Parkinson's Disease
the Psychiatry Advisor take:
For the first time in 10 years, a team of neurosurgeons this month will transplant cells from aborted fetuses into the brain of a person suffering from Parkinson's disease. The moratorium on replacement-therapy trials began in 2003 since trials involving the therapy were inconcklusive up to that point and the results were difficult to interpret.
The group, known as the Parkinson’s Disease Global Force, includes scientists from the European, US and Japanese teams about to embark on the trials.
More than 100 patients worldwide received the therapy as part of clinical trials before the moratorium. “But centers used different procedures and protocols — it was impossible to work out why some patients did very well and others didn’t benefit at all,” says neurologist Roger Barker at the University of Cambridge, UK, a member of working group.
The stem cell transplants will break a decade-long international moratorium on the controversial therapy.
Fetal-cell revival for Parkinson's
Sign Up for Free e-newsletters
Psychiatry Advisor Articles
- Belief That Abortion Harms Women's Mental Health Appears Misinformed
- Models Derived From Electronic Health Records Effective in Predicting Suicide Risk
- Probiotics Effective in Reducing Rehospitalization for Patients With Mania
- Autonomic Function May Have Directional Effect on Depression
- Predictors of Long-term Medication Adherence in Children With ADHD
- Court-Mandated Substance Abuse Treatment: Exploring the Ethics and Efficacy
- ADHD Treatments
- Pharmacogenetics in Psychiatry: Promising Developments and Potential Pitfalls
- Esketamine Nasal Spray: A New Treatment Possibility for Treatment-Resistant Depression
- Substance Abuse and Primary Psychosis: A Closer Look
- Schizophrenia, Major Depressive Disorder, Bipolar Disorder Linked With Abnormal Functional Connectivity
- ICF Core Sets for Schizophrenia Validated by International Cohort of Psychiatrists
- Transference in the Age of #MeToo: What Counts as Harassment From a Patient?
- Comorbid OCD Confers Greater Neurocognitive Impairment in Schizophrenia
- Smartphone Technology Allows Diagnosis of Autism in ResearchKit Feasibility Study